Mesoblast Ltd Adr (MESO)

Jan 26, 2026

Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment - GlobeNewswire Inc.

Jan 26, 2026

Jan 09, 2026

Mesoblast stock reaches 52-week high at 21.05 USD - Investing.com

Jan 09, 2026

Jan 09, 2026

Mesoblast stock reaches 52-week high at 21.05 USD By Investing.com - Investing.com India

Jan 09, 2026

Jan 02, 2026

Mesoblast announces board leadership changes as company evolves By Investing.com - Investing.com India

Jan 02, 2026

Dec 11, 2025

Mesoblast Shares (ASX:MSB) Stall at Resistance After Recent Rally - thebull.com.au

Dec 11, 2025

Dec 04, 2025

ETFs Investing in Mesoblast Limited Sponsored ADR Stocks - TradingView

Dec 04, 2025

Nov 26, 2025

Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - inkl

Nov 26, 2025

Nov 25, 2025

Jefferies upgrades Mesoblast stock to Buy on strong Ryoncil sales By Investing.com - Investing.com India

Nov 25, 2025

Oct 20, 2025

Mesoblast rides early ryoncil® momentum, tightens cash discipline, and prepares for next growth phase - Proactive financial news

Oct 20, 2025

Oct 17, 2025

Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 17, 2025

Oct 06, 2025

Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Oct 06, 2025

Sep 10, 2025

Mesoblast Limited $MESO Shares Acquired by Cubist Systematic Strategies LLC - Defense World

Sep 10, 2025

Sep 04, 2025

Mesoblast secures up to US$50m in fresh funding through convertible note agreements - Biotech Dispatch

Sep 04, 2025

Sep 03, 2025

Mesoblast Secures Option for US$50 Million Convertible Note Issuance - Sharecafe

Sep 03, 2025

Sep 03, 2025

Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes - ADVFN Brasil

Sep 03, 2025

Sep 03, 2025

Press Release: Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes - 富途牛牛

Sep 03, 2025

Aug 05, 2025

Canaccord Genuity initiates Mesoblast stock with Buy rating on cell therapy potential - Investing.com

Aug 05, 2025

Jul 18, 2025

Company’s Banking Stock: Dissecting a -4.28% Quarterly Revenue Decline Amid Growth - investchronicle.com

Jul 18, 2025

Jul 18, 2025

Mesoblast Ltd ADR Inc. (MESO) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Jul 18, 2025

Jul 18, 2025

BILL Holdings Inc Inc. (BILL) Price Performance: A Fundamental Analysis Perspective - investchronicle.com

Jul 18, 2025

Jul 18, 2025

Mesoblast stock soars after reporting first Ryoncil sales - Investing.com

Jul 18, 2025

Jul 06, 2025

Mesoblast Targets Accelerated FDA Approval For Heart Failure Drug Revascor - Sahm

Jul 06, 2025

Jul 01, 2025

Krispy Kreme Inc (DNUT) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Jul 01, 2025

Jun 20, 2025

Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 20, 2025

May 06, 2025

All Markets & Instruments Available to Trade - Capital.com

May 06, 2025

Jan 31, 2025

ASX Lunch Wrap: ASX and gold reset record highs; but Origin cuts its LNG forecast - Stockhead

Jan 31, 2025

Jan 10, 2025

Why are Mesoblast shares in a trading halt? - The Motley Fool Australia

Jan 10, 2025

Jan 09, 2025

Mesoblast Limited Initiates Trading Halt Pending Financing Announcement - TipRanks

Jan 09, 2025

Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024

Dec 30, 2024

Mesoblast Stock Soars to 52-Week High, Hits $19.15 - Investing.com

Dec 30, 2024

Sep 30, 2024

Mesoblast: Undervalued Due To Remestemcel-L's Substantial Growth Potential (NASDAQ:MESO) - Seeking Alpha

Sep 30, 2024

Aug 16, 2024

MESOMesoblast Ltd ADR Short Interest - Finviz

Aug 16, 2024

Apr 10, 2024

Mesoblast Limited: Back From The Dead (NASDAQ:MESO) - Seeking Alpha

Apr 10, 2024

Feb 12, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 12, 2024

Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024

Jan 22, 2024

Mesoblast Ltd Share Price ADR Each Representing 10 Ord Shares SPON - Hargreaves Lansdown

Jan 22, 2024

Mar 23, 2022

Philip R. Krause, M.D., Former FDA Deputy Chief For Vaccines, Joins Mesoblast Board - Barchart.com

Mar 23, 2022

Jan 16, 2021

MESO Financial Statements & ChartsMesoblast LtdAdr MacroTrends - CMLviz

Jan 16, 2021

Jan 11, 2021

MESO Pivot Points, Technical Analysis and Moving AveragesMesoblast LtdAdr Technicals - CMLviz

Jan 11, 2021

Dec 16, 2020

Maxim Group Stick to Their Buy Rating for Mesoblast Ltd - Investing.com

Dec 16, 2020

Dec 02, 2020

The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod - Yahoo Finance

Dec 02, 2020

Nov 19, 2020

Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy - Novartis

Nov 19, 2020

Jul 15, 2020

How many stocks fighting COVID-19 have maintained their momentum? - Stockhead

Jul 15, 2020

Mar 18, 2020

The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates - Yahoo Finance

Mar 18, 2020

Jul 21, 2017

MESO Stock Price and Chart — NASDAQ:MESO - TradingView

Jul 21, 2017

Jul 20, 2017

MSB Stock Price and Chart — ASX:MSB - TradingView — Track All Markets

Jul 20, 2017

May 16, 2017

Mesoblast Limited (MESO) stock price, news, quote and history - Yahoo Finance UK

May 16, 2017

May 06, 2016

MESO Stock Price | Mesoblast Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch

May 06, 2016